RECOVER-TLC to hold next webinar January 23, 2026
NIH and FNIH leaders will provide updates and answer questions about RECOVER’s latest efforts to identify safe and effective treatments for Long COVID.
The National Institute of Allergy and Infectious Diseases (NIAID) and the Foundation for the National Institutes of Health (FNIH) will host a webinar on Friday, January 23, 2026, from 12:00-1:00 pm ET. During this online event, NIH leaders will provide updates on RECOVER-Treating Long COVID (RECOVER-TLC), the next phase of RECOVER clinical trials.
Acting NIAID Director Jeffery K. Taubenberger, MD, PhD, and FNIH President and CEO Julie L. Gerberding, MD, MPH, will share their insights and answer audience questions. Anyone is welcome to submit comments and questions in advance.
Register for the January 23 webinar.
Following the webinar, a recording will be available on the FNIH website.